Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nicobrand is a leading manufacturer of high-purity nicotine and nicotine-derived products for the global pharmaceutical industry. Based in Northern Ireland, the company specializes in the production of Active Pharmaceutical Ingredients (APIs) used primarily in Nicotine Replacement Therapy (NRT) products such as gums, patches, and lozenges. Their product portfolio includes nicotine resinate, nicotine polacrilex, and various nicotine dilutions, all manufactured under stringent Good Manufacturing Practice (GMP) standards. As a member of the CNT Group, Nicobrand provides contract development and manufacturing services (CDMO) to support clients from formulation through to commercial supply. The company is recognized for its technical expertise in nicotine complexation and its commitment to regulatory compliance in highly controlled markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nicobrand.